Advertisement
Quick Menu

Upcoming Journals

Journal of Advances in Medicine and Medical Research

Journal of Advances in Medicine and Medical Research, ISSN: 2456-8899, ISSN: 2231-0614 (Past),Vol.: 22, Issue.: 10

Minireview-article

Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy

 

N. Inayet1*, A. Poullis1 and J. Hayat1

1St George’s Hospital, London, England.

 

Article Information

Editor(s):

(1) Muhammad Torequl Islam, Nuclear of Pharmaceutical Technology (NTF), Federal University of Piaui, Brazil.

Reviewers:

(1) Robert Jensen, National Institutes of Health, USA.

(2) Naser Ashraf Tadvi, Majmaah University, Kingdom of Saudia Arabia.

(3) D. S. Pushparani, Sri Ramaswami Memorial University, India.

(4) Magyar Ioan, University of Oradea, Romania.

Complete Peer review History: http://www.sciencedomain.org/review-history/20020

 

Abstracts

 

Proton pump inhibitors (PPIs) are currently the mainstay of treatment for gastro-oesophageal reflux disease, peptic ulcer disease and dyspepsia. In this area, they have enjoyed remarkable success and there are many patients worldwide who use PPIs on a long-term basis. In recent years concerns regarding adverse effects of PPIs have emerged frequently in the medical literature with several small and large scale studies conducted to look into this. The main areas of interest have been increased risk of neuroendocrine tumours, increased risk of dementia, increased risk of infections (enteric, pneumonia, Clostridium difficle), cardiovascular, renal and lower gastrointestinal side effects and effects on mineral and vitamin metabolism. In this review article, we focus mainly on the metabolic consequences of long term PPI therapy.

 

Keywords :

Iron deficiency; B12 deficiency; calcium malabsorption; hypomagnesaemia; osteoporosis.

 

Full Article - PDF    Page 1-7    Article Metrics

 

DOI : 10.9734/JAMMR/2017/34805

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.